Osteocool RF Ablation System
Device Neuro Pain (includes Interventional)
PDI 00643169871625
General payments
$1,205,241
Research payments
$188,911
Through program year 2025, $1,205,241 in general payments and $188,911 in research payments were reported against Osteocool RF Ablation System (Neuro Pain (includes Interventional)).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $151,146 | 1,633 |
| 2024 | General | $308,847 | 1,941 |
| 2024 | Research | $86,517 | 20 |
| 2023 | General | $339,429 | 2,307 |
| 2023 | Research | $56,859 | 16 |
| 2022 | General | $405,819 | 2,528 |
| 2022 | Research | $45,535 | 7 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 58 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 43 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
8,409 general · 43 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.